Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
19.7%
% of BBP's 65 holdings also in CNCR
16.7%
% of CNCR's 72 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
SPRINGWORKS THERAPEUTICS, INC. | 2.1% | 2.7% | 2.1% |
|
EXELIXIS INC | 1.8% | 2.7% | 1.8% |
|
IMMUNITYBIO INC | 1.6% | 1.8% | 1.6% |
 |
IMMUNOCORE HOLDINGS PLC SPONSORED ADR | 1.6% | 1.8% | 1.6% |
|
BLUEPRINT MEDICINES CORP. | 1.5% | 2.1% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to CNCR
|
INTRA-CELLULAR THERAPIES INC | 2.6% |
|
BEIGENE LTD. SPONSORED ADR | 2.3% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.2% |
|
SAGE THERAPEUTICS INC | 2.2% |
|
AXSOME THERAPEUTICS, INC. | 2.1% |
|
GILEAD SCIENCES INC | 2.1% |
|
HALOZYME THERAPEUTICS INC | 2.1% |
|
TG THERAPEUTICS INC | 2.1% |
|
AMGEN INC | 2.0% |
|
BRIDGEBIO PHARMA, INC. | 1.9% |
BBP Underweight Relative to CNCR
|
RECURSION PHARMACEUTICALS, INC CLASS | -3.6% |
|
INTREXON CORP | -3.2% |
|
GENELUX CORP. | -2.5% |
|
BRISTOL-MYERS SQUIBB CO | -2.4% |
|
COMPASS THERAPEUTICS, INC. | -2.4% |
|
2SEVENTY BIO, INC. | -2.1% |
|
SCHRODINGER, INC. | -2.0% |
|
REPLIMUNE GROUP, INC. | -2.0% |
|
ZYMEWORKS INC. | -2.0% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | -2.0% |